ISAR Webinar Series

24th Apr 2019 Pre-Clinical Services through the NIAID Division of Microbiology and Infectious Diseases - Mindy Davis, PhD, Ann Eakin, PhD, Heather Greenstone, PhD 

24th Jan 2019 Chronic hepatitis B: novel treatment targets and perspectives for cure - Fabien Zoulim

4th Dec 2018 Small molecule-induced target degradation as an antiviral strategy -  Priscilla L. Yang 

18th Oct 2018 Integrating Clinical Research into Epidemic Response by studying the Ebola Experience - Charles Wells

2nd Oct 2018 Discovery and development of norovirus antivirals: current issues - Randall Lanier

19th Jul 2018 Yellow Fever: Recent Resurgence and Challenges for Prevention and Control -  Thomas P Monath

29th Mar2018 Therapies for Norovirus infection: Targets, tools, and status of discovery - Brent Korba

28th Feb 2018 Zika virus: Mechanisms for enhanced disease and vaccine development - Pei Yong Shi

5th Jan 2018 CRISPR-Cas9 whole genome screens identify host factors required for arbovirus infection - Mike Diamond

4th Dec 2017 Antivirals: much accomplished, far to go - Johan Neyts 

8th Nov 2017 Antibodies against Viral Hemorrhagic Fevers: It takes a village - Erica Ollmann Saphire

20th Apr 2017 Mechanisms of neutralization of viruses mediated by human antibodies - James Crowe

29th Mar 2017 Tenofovir in the treatment of HIV: from TDF to TAF - Erik DeClerq

23rd Feb 2017 ALN-HBV, An Investigational RNAi Drug for the Treatment of Chronic Hepatitis B - Laura Sepp-Lorenzino

19th Jan 2017 Hepatitis C virus: From Discovery to Cure - Charlie Rice

9th Dec 2016 Designing Antiviral Screens and Assays: Common Pitfalls and How to Avoid Them - Rick Wobbe

31st Oct 2016 Zika Virus: Emergence, Biology, disease Models - Scott Weaver